Nature Communications (Feb 2020)

A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation

  • Stefanie Voigt,
  • Kai R. Sterz,
  • Fabian Giehler,
  • Anne-Wiebe Mohr,
  • Joanna B. Wilson,
  • Andreas Moosmann,
  • Arnd Kieser

DOI
https://doi.org/10.1038/s41467-020-14502-x
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 16

Abstract

Read online

IKK2 is the main mediator of the NF-kappaB pathway. Here, the authors demonstrate that LMP1 sustains the survival of Epstein-Barr virus-transformed human B cells and post-transplant lymphoma through IKK2 that induces JNK signaling through TPL2.